We leverage data science, purpose-built technology and financial engineering to manage the budget-busting impact of high-cost advanced therapies in a unique way that is significantly more affordable, flexible, easy to implement, and provides greater benefits.
Unpredictable high-cost claims are putting a strain on resources and creating an uneven playing field for payors. For many, the cost of a single event can be financially devastating. Unfortunately, existing healthcare business models and other risk management products are not suited for this growing problem.
PayRx offers solutions that enable all payors to monitor, plan for, and pay for the fast-growing world of life-changing and curative treatments including cell and gene therapies.
Powered by our data science and predictive analytics capabilities, we work with health plans and employers to monitor, plan, and pay for high cost advanced therapies (HCAT)
Working with the world's leading banks, we provide tailor-made financing solutions for payers, for the most advanced therapies.
As CFO, I'm able to see the value PayRx delivers through their unique risk financing solutions and forecasting capabilities that help us plan for and manage our exposure to high-cost, next generation therapies.
PayRx is the industry leader in delivering tailored, on-demand precision risk financing solutions and analytics for self-funded employers and health plans to enable greater patient access to high-cost advanced therapies. We leverage data science, purpose-built technology and financial engineering to manage the cost impact of advanced therapies in a unique way that is significantly more affordable, flexible, and provides greater benefits.
